Skip to content
Home/Companies/Biotech/Nuclera
NU

Nuclera

Biotech·United Kingdom·Active·2yr hold

Nuclera is a biotech company, headquartered in UK.

Entry
2024
Hold
2yr
Status
Active
Est. EV
–

Who owns Nuclera?

Nuclera is currently owned by Cambridge Innovation Capital through CIC Fund II (2022 vintage), since 2024. Across its history, Nuclera has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-06-30

Cambridge Innovation Capital
Most recent investor
Cambridge Innovation Capital
CIC Fund II · 2022 · VC
2 ownership periods · full history below

Key facts

HQUK
SectorBiotech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Future Planet Capital and Cambridge Innovation Capital since 2022.
Co-invest · 2 holders · 2022 · present
Future Planet Capital
Future Planet CapitalActive
2022 · present · Future Planet Fund I · 2018 · VC
MOIC
–
Cambridge Innovation Capital
Cambridge Innovation CapitalActive
2024 · present · CIC Fund II · 2022 · VC
MOIC
–

More from CIC Fund II

Other portfolio companies in the same fund.

Immutrin
Active
BiotechUK· 2025
TRIMTECH Therapeutics
Active
BiotechUK· 2025
Forefront RF
Active
TelecomUK· 2024
Complement Therapeutics
Active
BiotechUK· 2023
Mosaic TX
Active
BiotechUK· 2023
T-Therapeutics
Active
BiotechUK· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings